Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
Theiss-Nyland K, Shakya M, Colin-Jones R, Voysey M, Smith N, Karkey A, Dongol S, Pant D, Farooq YG, Mazur O, Darlow C, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ. Theiss-Nyland K, et al. Among authors: darlow c. Clin Infect Dis. 2021 Nov 16;73(10):1950. doi: 10.1093/cid/ciab802. Clin Infect Dis. 2021. PMID: 34698813 Free PMC article. No abstract available.
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model.
Gibani MM, Jones E, Barton A, Jin C, Meek J, Camara S, Galal U, Heinz E, Rosenberg-Hasson Y, Obermoser G, Jones C, Campbell D, Black C, Thomaides-Brears H, Darlow C, Dold C, Silva-Reyes L, Blackwell L, Lara-Tejero M, Jiao X, Stack G, Blohmke CJ, Hill J, Angus B, Dougan G, Galán J, Pollard AJ. Gibani MM, et al. Among authors: darlow c. Nat Med. 2019 Jul;25(7):1082-1088. doi: 10.1038/s41591-019-0505-4. Epub 2019 Jul 3. Nat Med. 2019. PMID: 31270506 Free PMC article. Clinical Trial.
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.
Darlow CA, Docobo-Perez F, Farrington N, Johnson A, McEntee L, Unsworth J, Jimenez-Valverde A, Gastine S, Kolamunnage-Dona R, de Costa RMA, Ellis S, Franceschi F, Standing JF, Sharland M, Neely M, Piddock L, Das S, Hope W. Darlow CA, et al. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0029321. doi: 10.1128/AAC.00293-21. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33972238 Free PMC article.
Susceptibility of OXA-48-like-producing Enterobacterales to flomoxef.
Owen V, Harper N, Dubey V, Gerada A, Boyd SE, Darlow CA. Owen V, et al. Among authors: darlow ca. Clin Microbiol Infect. 2024 Dec;30(12):1606-1608. doi: 10.1016/j.cmi.2024.07.017. Epub 2024 Jul 26. Clin Microbiol Infect. 2024. PMID: 39067511 No abstract available.
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting.
Sadouki Z, McHugh TD, Aarnoutse R, Ortiz Canseco J, Darlow C, Hope W, van Ingen J, Longshaw C, Manissero D, Mead A, Pelligand L, Phee L, Readman J, Ruth MM, Standing JF, Stone N, Wey EQ, Kloprogge F. Sadouki Z, et al. Among authors: darlow c. J Antimicrob Chemother. 2021 Aug 12;76(9):2252-2259. doi: 10.1093/jac/dkab160. J Antimicrob Chemother. 2021. PMID: 34179966 Free PMC article.
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
Darlow CA, Farrington N, Johnson A, McEntee L, Unsworth J, Jimenez-Valverde A, Kolamunnage-Dona R, Da Costa RMA, Ellis S, Franceschi F, Sharland M, Neely M, Piddock LJV, Das S, Hope W. Darlow CA, et al. J Antimicrob Chemother. 2022 Apr 27;77(5):1334-1343. doi: 10.1093/jac/dkac038. J Antimicrob Chemother. 2022. PMID: 35170719 Free PMC article.
21 results